ArticleInternational journal of hematology2014

Factors associated with effects of 90Y-ibritumomab tiuxetan in patients with relapsed or refractory low-grade B cell non-Hodgkin lymphoma: single-institution experience with 94 Japanese patients in rituximab era.

Naokuni Uike et al.PubMed ↗Publisher ↗

No numbers read from the abstract.